Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Director/PDMR Shareholding

28 Apr 2016 14:32

RNS Number : 7045W
Chesnara PLC
28 April 2016
 

 

Annex DTR3

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

 

All relevant boxes should be completed in block capital letters.

 

1.

Name of the issuer: CHESNARA PLC

 

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

 

3.

Name of person discharging managerial

responsibilities/director

 

JOHN DEANE

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person. N/A

 

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest 1

 

N/A

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

 

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

N/A

8.

State the nature of the transaction

 

 

N/A

9.

Number of shares, debentures or financial

instruments relating to shares acquired

 

N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

 

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

13.

Price per share or value of transaction

 

N/A

 

14.

Date and place of transaction

 

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

16.

Date issuer informed of transaction

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes:

 

17.

Date of grant

 

28 APRIL 2016

 

18.

Period during which or date on which exercisable

 

GRANT 1

THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

GRANT 2

SUBJECT TO THE ACHIEVEMENT OF THE PERFORMANCE TARGET, THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

19.

Total amount paid (if any) for grant of the option - NIL

20.

Description of shares or debentures involved (class and number)

 

GRANT 1

26,575 ORDINARY SHARES OF 5P EACH

 

 

GRANT 2

133,017 ORDINARY SHARES OF 5P EACH

 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise - NIL

 

22.

Total number of shares or debentures over which options held following notification

 

250,529 ORDINARY SHARES OF 5P EACH

 

23.

Any additional information

 

GRANT 1

GRANTED UNDER THE CHESNARA 2014 SHORT-TERM INCENTIVE SCHEME. THE OPTION IS NOT SUBJECT TO A PERFORMANCE TARGET.

 

GRANT 2

GRANTED UNDER THE CHESNARA 2014 LONG-TERM INCENTIVE SCHEME. THE OPTION IS SUBJECT TO A PERFORMANCE TARGET WHICH IS BASED ON 50% ON TSR, 50% ON EMBEDDED VALUE OF THE COMPANY OVER A PERIOD OF THREE FINANCIAL YEARS.

 

 

24.

Name of contact and telephone number for queries

 

ZOE KUBIAK +44 (0) 1772 972050

 

 

 

1.

Name of the issuer: CHESNARA PLC

 

 

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

 

3.

Name of person discharging managerial

responsibilities/director

 

DAVID RIMMINGTON

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person. N/A

 

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial

interest 1

 

N/A

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

 

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

N/A

8.

State the nature of the transaction

 

 

N/A

9.

Number of shares, debentures or financial

instruments relating to shares acquired

 

N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

 

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

13.

Price per share or value of transaction

 

N/A

 

14.

Date and place of transaction

 

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) N/A

 

16.

Date issuer informed of transaction

N/A

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes:

 

17.

Date of grant

 

28 APRIL 2016

 

18.

Period during which or date on which exercisable

 

GRANT 1

THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

GRANT 2

SUBJECT TO THE ACHIEVEMENT OF THE PERFORMANCE TARGET, THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

19.

Total amount paid (if any) for grant of the option - NIL

 

 

20.

Description of shares or debentures involved (class and number)

 

GRANT 1

15,434 ORDINARY SHARES OF 5P EACH

 

 

GRANT 2

71,259 ORDINARY SHARES OF 5P EACH

 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise - NIL

 

22.

Total number of shares or debentures over which options held following notification

 

196,604 ORDINARY SHARES OF 5P EACH

 

23.

Any additional information

 

GRANT 1

GRANTED UNDER THE CHESNARA 2014 SHORT-TERM INCENTIVE SCHEME. THE OPTION IS NOT SUBJECT TO A PERFORMANCE TARGET.

 

GRANT 2

GRANTED UNDER THE CHESNARA 2014 LONG-TERM INCENTIVE SCHEME. THE OPTION IS SUBJECT TO A PERFORMANCE TARGET WHICH IS BASED ON 50% ON TSR, 50% ON EMBEDDED VALUE OF THE COMPANY OVER A PERIOD OF THREE FINANCIAL YEARS.

 

24.

Name of contact and telephone number for queries: ZOE KUBIAK +44 (0) 1772 972050

 

 

 

1.

Name of the issuer: CHESNARA PLC

 

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

 

3.

Name of person discharging managerial

responsibilities/director

 

FRANK HUGHES

4.

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person. N/A

 

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial

interest 1

 

N/A

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

 

N/A

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

N/A

8.

State the nature of the transaction

 

 

N/A

9.

Number of shares, debentures or financial

instruments relating to shares acquired

 

N/A

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

 

N/A

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

N/A

 

13.

Price per share or value of transaction

 

N/A

 

14.

Date and place of transaction

 

N/A

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

16.

Date issuer informed of transaction

 

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes:

 

17.

Date of grant

 

28 APRIL 2016

 

18.

Period during which or date on which exercisable

 

GRANT 1

THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

GRANT 2

SUBJECT TO THE ACHIEVEMENT OF THE PERFORMANCE TARGET, THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2019 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2026 IF NOT EXERCISED BEFORE THAT DATE.

 

19.

Total amount paid (if any) for grant of the option - NIL

20.

Description of shares or debentures involved (class and number)

 

GRANT 1

14,027 ORDINARY SHARES OF 5P EACH

 

 

GRANT 2

50,364 ORDINARY SHARES OF 5P EACH

 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise - NIL

 

22.

Total number of shares or debentures over which options held following notification

 

182,768 ORDINARY SHARES OF 5P EACH

 

23.

Any additional information

 

GRANT 1

GRANTED UNDER THE CHESNARA 2014 SHORT-TERM INCENTIVE SCHEME. THE OPTION IS NOT SUBJECT TO A PERFORMANCE TARGET.

 

GRANT 2

GRANTED UNDER THE CHESNARA 2014 LONG-TERM INCENTIVE SCHEME. THE OPTION IS SUBJECT TO A PERFORMANCE TARGET WHICH IS BASED ON 50% ON TSR, 50% ON EMBEDDED VALUE OF THE COMPANY OVER A PERIOD OF THREE FINANCIAL YEARS.

 

24.

Name of contact and telephone number for queries

 

ZOE KUBIAK +44 (0) 1772 972050

 

 

 

 

Name of authorised official of issuer responsible for making notification

Zoe Kubiak

 

Date of notification 28 April 2016

 

 

 

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGUUWCUPQGWR
Date   Source Headline
1st Jun 20267:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
29th May 20267:00 amRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSDirector/PDMR Shareholding
14th May 20267:00 amRNSDirector/PDMR Shareholding
12th May 20262:00 pmRNSResult of AGM
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSAdmission to Trading
10th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 20267:00 amRNSNotice of AGM
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:40 pmRNSDirector/PDMR Shareholding
27th Mar 20267:00 amRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSHolding(s) in Company
27th Feb 20267:00 amRNSUpdated Financial Framework and Notice of Results
17th Feb 20267:00 amRNSAcquisition
2nd Feb 20267:00 amRNSCompletion of HSBC Life (UK) Limited Acquisition
30th Jan 20262:00 pmRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
12th Dec 20251:45 pmRNSRegulatory Approval
12th Dec 20257:00 amRNSChange of Registered Office
9th Dec 20257:00 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSHolding(s) in Company
7th Nov 20257:00 amRNSTotal Voting Rights
30th Oct 20257:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSBlock listing Interim Review
27th Oct 202512:04 pmRNSDirector/PDMR Shareholding
6th Oct 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
14th Aug 20257:00 amRNSNotice of Interim Results
13th Aug 20256:00 pmRNSPrimary Health Properties
30th Jul 20257:00 amRNS£150 MILLION RESTRICTED TIER 1 BOND ISSUE
28th Jul 20257:00 amRNSDirector/PDMR Shareholding
23rd Jul 202510:52 amRNSResult of Rump Placing
23rd Jul 20258:15 amRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSAnnouncement re: Rights Issue
8th Jul 20257:00 amRNSAdmission of Nil Paid Rights
3rd Jul 202512:10 pmRNSPublication of a Prospectus
3rd Jul 20257:00 amRNSAcquisition & Rights Issue
1st Jul 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSDirectorate Change
23rd May 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.